Skip to content

alliance for global health

Primary Menu
  • home
  • About
    • History
    • Why the Alliance
    • Board
    • Members of the Alliance
    • Secretariat
  • our work
    • Erasmus+ BACE Project
    • Annual Conference
    • Global Health Academy
    • Global Health Curricula
  • Quarterly Bulletin
  • contact
Join the alliance
  • Home
  • Global Health News
  • Alzheimer’s drug study yields positive results, say makers Eisai and Biogen

Alzheimer’s drug study yields positive results, say makers Eisai and Biogen

admin October 1, 2022

Alzheimer’s drug study yields positive results, say makers Eisai and Biogen

admin

See author's posts

Continue Reading

Previous: European countries see early signs of autumn COVID-19 rise
Next: 3 in 5 globally say their healthcare system is overstretched

Related Stories

WHO/Europe, UNFPA and partners commit to take measures to advance midwifery

WHO/Europe, UNFPA and partners commit to take measures to advance midwifery

July 17, 2024
ELA Tier 2: Strengthening transformational leadership for health to drive health systems change

ELA Tier 2: Strengthening transformational leadership for health to drive health systems change

July 17, 2024
Destruction and Devastation: One Year of Russia’s Assault on Ukraine’s Health Care System

Destruction and Devastation: One Year of Russia’s Assault on Ukraine’s Health Care System

July 5, 2024
Copyright © All rights reserved | MoreNews by AF themes.